山东大学学报(医学版) ›› 2015, Vol. 53 ›› Issue (2): 48-51.doi: 10.6040/j.issn.1671-7554.0.2014.768
徐忠阳, 王立启, 徐振兴, 赵乾, 朱世明
XU Zhongyang, WANG Liqi, XU Zhenxing, ZHAO Qian, ZHU Shiming
摘要: 目的 探讨原发性高血压患者血清RhoA激酶(ROCK)水平与血压变异性(BPV)及颈动脉内膜中层厚度(IMT)的关系.方法 选取2013年9月至2014年8月山东大学附属济南市中心医院心内科原发性高血压患者73例,根据血清ROCK1水平分为高表达组(n=37)和低表达组(n=36).选取同期体检血压正常者40例为正常对照组.采用Human Rock1 Elisa kit及酶标仪检测血清ROCK1水平;监测24 h血压,记录24 h、白昼、夜间血压均值以及相应的血压标准差;采用彩色多普勒超声仪测量颈动脉IMT.结果 高表达组和低表达组血清ROCK1水平明显高于正常对照组(P<0.01);高表达组24 h收缩压标准差(24hSSD)、日间收缩压标准差(dSSD)、夜间收缩压标准差(nSSD)均明显高于低表达组(P<0.05);高表达组和低表达组颈动脉IMT比正常对照组明显增厚,高表达组颈动脉IMT比低表达组明显增厚(P<0.05);血清ROCK1水平与24hSSD、dSSD、nSSD及颈动脉IMT呈显著正相关性(P<0.05).结论 高血压患者血压变异性增高与RhoA/ROCK1信号通路高表达有关,RhoA/ROCK1信号通路过度激活可导致颈动脉IMT增厚及颈动脉粥样硬化斑块(AS)形成.
中图分类号:
[1] 宫丽丽, 方莲花, 杜冠华. 心血管疾病治疗的新靶点—Rho激酶[J]. 中国药学杂志, 2008, 43(1):1-4. [2] Wibberley A, Chen Z, Hu E, et al. Expression and functional role of Rho-kinase in rat urinary bladder smooth muscle[J]. Br J Pharmacol, 2003, 138(5):757-766. [3] Zhou Q, Gensch C, Liao JK. Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease[J]. Trends Pharmacol Sci, 2011, 32(3):167-173. [4] Mueller BK, Mack H, Teusch N. Rho-kinase: a promising drug target for neurological disorders[J]. Nat Rev Drug Discov, 2005, 4(5):387-398. [5] Gao HC, Zhao H, Zhang WQ, et al. The role of the Rho/Rock signaling pathway in the pathogenesis of acute ischemic myocardial fibrosis in rat models[J]. Exp Ther Med, 2013, 5(4):1123-1128. [6] 蔡茜, 吴尚洁, 赵雪峰. 慢性阻塞性肺疾病相关性肺动脉高压患者外周血单核细胞Rho激酶水平测定[J]. 中南大学学报:医学版, 2012, 37(5):453-457. CAI Qian, WU Shangjie, ZHAO Xuefeng. Measurement of Rho-kinase in peripheral blood monocytes in patients with pulmonary arterial hypertension related to chronic obstructive pulmonary diseases[J]. J Cent South Univ:Med Sci, 2012, 37(5):453-457. [7] Nakagawa O, Fujisawa K, Ishizaki T, et al. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice[J]. FEBS Lett, 1996, 392(2):189-193. [8] Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II; modulated by G proteins, kinases, and myosin phosphatase[J]. Physiol Rev, 2003, 83(4):1325-1358. [9] Somlyo AP, Somlyo AV. Signal transduction by G proteins, Rhokinase and protein phosphatase to smooth muscle and non-musclemyosin II[J]. J Physiol, 2000, 522(2): 177-185. [10] Mukai Y, Shimokawa H, Matoba T. Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension[J]. FASEB J, 2001, 15(6):1062-1064. [11] Ito K, Hirooka Y, Sakai K, et al. Rho/Rho-kinase pathway in brain stem contributes to blood pressure regulation via sympathetic nervous system: possible involvement in neural mechanisms of hypertension[J]. Circ Res, 2003, 92(12):1337-1343. [12] Mancia G, Grassi G. Mechanisms and clinical implications of blood pressure variability[J]. J Cardiovasc Pharmacol, 2000, 35(4):15-19. [13] 胡建新, 胡宪珍, 张润香, 等. 血压变异性与血浆一氧化氮、内皮素含量的关系[J]. 江西医学院学报, 2004, 44(5):38-39. HU Jianxin, HU Xianzhen, ZHANG Runxiang, et al.The relationship between blood pressure variability and the plasma levels of nitric oxide and endothelin-1[J]. Acta Academiae Medicinae Jiangxi, 2004, 44(5):38-39. [14] Shibasaki M, Durand S, Davis SL, et al. Endogenous nitric oxide attenuates neutrally mediated cutaneous vasoconstriction[J]. J Physiol, 2007, 585(2):627-634. [15] Alexander J S. Rho, tyrosine kinase, Ca2+, and junctions in endothelial hyperpermeability[J]. Circ Res, 2000, 87(4):268-271. [16] Worthylake RA, Lemoine S, Watson JM, et al. RhoA is required for monocyte tail retraction during transendothelial migration[J]. J Cell Biol, 2001, 154(1):147-160. [17] 刘春南, 余首先, 赵晓宇. Rho激酶在心血管疾病中新进展及Rho激酶抑制剂的应用[J]. 心脏杂志, 2012, 24(4):521-524. LIU Chunnan, YU Shouxian, ZHAO Xiaoyu, et al. Rho kinase in cardiovascular diseases and applications for Rho kinase inhibition:Current progress[J]. Chin Heart J, 2012, 24(4):521-524. [18] Sander D, Kukla C, Klingelhfer J, et al. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: A 3-year follow-up study[J]. Circulation, 2000, 102(13):1536-1541. |
[1] | 吴逸南 葛志明 李方 贺红 姜虹 张运. 自发性高血压大鼠肾脏血管紧张素转换酶2的表达[J]. 山东大学学报(医学版), 2209, 47(6): 5-. |
[2] | 付洁琦,张曼,张晓璐,李卉,陈红. Toll样受体4抑制过氧化物酶体增殖物激活受体γ加重血脂蓄积的分子机制[J]. 山东大学学报 (医学版), 2020, 1(7): 24-31. |
[3] | 尹妮,杨关林,姜钧文,王春田,王凤耀,贾连群,高晓宇,潘嘉祥,李芹,李佳,冯元洁,高玉竹,周鹤,张哲. 巴马小型猪冠状动脉粥样硬化模型的评价方法[J]. 山东大学学报(医学版), 2017, 55(7): 1-5. |
[4] | 于涛,刘焕乐,冯新,徐付印,陈亚飞,薛付忠,张成琪. 基于健康管理队列的高血压风险预测模型[J]. 山东大学学报(医学版), 2017, 55(6): 61-65. |
[5] | 严芳英,单晓兰,李静媛,张杰,闫雪芳,杨奕,卜培莉. 吡格列酮通过调控Sirt3改善高血压引起的心肌纤维化机制[J]. 山东大学学报(医学版), 2017, 55(5): 13-18. |
[6] | 李睿,马伟红,任满意,赵萌萌,姜珊,巨媛媛,郭颖,孙昭辉,隋树建. TWEAK与原发性高血压患者心脏重塑的相关性[J]. 山东大学学报(医学版), 2017, 55(5): 49-55. |
[7] | 王维军,周宁全,王超. CT定位微创徒手穿刺软通道技术治疗中等量高血压脑出血68例[J]. 山东大学学报(医学版), 2017, 55(5): 61-65. |
[8] | 张华,庄霞,刘振东,刁玉涛,杜佳晨,崔谊. 磁共振弥散张量成像技术评价高血压对年轻成年人脑白质损伤[J]. 山东大学学报(医学版), 2017, 55(5): 56-60. |
[9] | 张云华,李杰. 颈动脉斑块内新生血管显影程度及血浆Lp-PLA2水平对急性脑梗死的临床诊断价值[J]. 山东大学学报(医学版), 2017, 55(3): 112-116. |
[10] | 魏丹丹,张澄. 血管紧张素Ⅳ型受体过表达对早期动脉粥样硬化斑块形成的影响[J]. 山东大学学报(医学版), 2016, 54(8): 1-5. |
[11] | 王丹,亓恒涛,孙书珍. 原发性肾病综合征儿童颈动脉结构和功能改变[J]. 山东大学学报(医学版), 2016, 54(5): 88-91. |
[12] | 孙鹏飞,孟晓,张凯,黎莉. 抵抗素样分子 β在动脉粥样硬化斑块稳定性中的作用[J]. 山东大学学报(医学版), 2016, 54(3): 1-4. |
[13] | 王立轩,张璐,许新,李思雪,刘敏,王亚萍,马慧娟. 慢性间歇性低压低氧通过PI3K依赖的eNOS活化增强大鼠胸主动脉舒张[J]. 山东大学学报(医学版), 2016, 54(2): 11-15. |
[14] | 李雪丽,徐丽君. 以孤立性眩晕为首发症状的双侧对称性桥臂梗死1例[J]. 山东大学学报(医学版), 2016, 54(12): 90-92. |
[15] | 王小飞, 王成伟, 王志刚, 丁璇, 王敏卿. 应用Enterprise支架治疗动脉粥样硬化性椎-基底动脉狭窄的探讨[J]. 山东大学学报(医学版), 2015, 53(8): 44-48. |
|